Periodic Reporting for period 2 - METAdiag (Detecting serious diseases due to abnormal cellular energetics)

METAFORA develops a disruptive blood-based In Vitro Diagnostic platform called METAdiag. METAdiag monitors cells’ energetic needs thanks to unique, proprietary biomarkers (Receptor Binding Domains or RBDs), able to quantify nutrient transporters used by cells to feed on...